News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
377,303 Results
Type
Article (14903)
Company Profile (115)
Press Release (362280)
Multimedia
Podcasts (50)
Webinars (9)
Section
Business (112923)
Career Advice (468)
Deals (18677)
Drug Delivery (41)
Drug Development (31449)
Employer Resources (51)
FDA (8891)
Job Trends (7708)
News (173469)
Policy (12460)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Standard (3)
Academia (1340)
Accelerated approval (10)
Allergies (71)
Alliances (34952)
ALS (43)
Alzheimer's disease (633)
Antibody-drug conjugate (ADC) (179)
Approvals (9096)
Artificial intelligence (445)
Autoimmune disease (61)
Automation (31)
Bankruptcy (132)
Best Places to Work (6527)
BIOSECURE Act (7)
Biosimilars (31)
Biotechnology (85)
Bladder cancer (62)
Brain cancer (27)
Breast cancer (263)
Cancer (2194)
Cardiovascular disease (149)
Career advice (425)
Career pathing (9)
CAR-T (200)
CDC (8)
Cell therapy (490)
Cervical cancer (21)
Clinical research (26050)
Collaboration (1232)
Compensation (233)
Complete response letters (8)
COVID-19 (1227)
CRISPR (85)
C-suite (484)
Cystic fibrosis (60)
Data (2651)
Decentralized trials (1)
Denatured (26)
Depression (44)
Diabetes (211)
Diagnostics (5146)
Digital health (36)
Diversity (7)
Diversity, equity & inclusion (9)
Drug discovery (164)
Drug pricing (19)
Drug shortages (4)
Duchenne muscular dystrophy (87)
Earnings (40610)
Editorial (9)
Employer branding (8)
Employer resources (45)
Events (53549)
Executive appointments (550)
FDA (10510)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (5)
Frontotemporal dementia (8)
Funding (899)
Gene editing (171)
Generative AI (38)
Gene therapy (345)
GLP-1 (302)
Government (1286)
Grass and pollen (3)
Guidances (225)
Healthcare (9940)
HIV (23)
Huntington's disease (13)
IgA nephropathy (26)
Immunology and inflammation (68)
Immuno-oncology (19)
Indications (51)
Infectious disease (1368)
Inflammatory bowel disease (81)
Inflation Reduction Act (5)
Influenza (74)
Intellectual property (151)
Interviews (54)
IPO (8071)
IRA (10)
Job creations (1443)
Job search strategy (371)
JPM (20)
Kidney cancer (6)
Labor market (24)
Layoffs (131)
Leadership (7)
Legal (2539)
Liver cancer (43)
Longevity (6)
Lung cancer (245)
Lymphoma (172)
Machine learning (34)
Management (18)
Manufacturing (525)
MASH (36)
Medical device (11857)
Medtech (11906)
Mergers & acquisitions (11241)
Metabolic disorders (400)
Multiple sclerosis (62)
NASH (3)
Neurodegenerative disease (121)
Neuropsychiatric disorders (20)
Neuroscience (1096)
NextGen: Class of 2026 (3546)
Non-profit (1546)
Now hiring (15)
Obesity (140)
Opinion (97)
Ovarian cancer (92)
Pain (106)
Pancreatic cancer (101)
Parkinson's disease (121)
Partnered (20)
Patents (301)
Patient recruitment (245)
Peanut (31)
People (33721)
Pharmaceutical (18)
Pharmacy benefit managers (3)
Phase 1 (9535)
Phase 2 (11695)
Phase 3 (7628)
Pipeline (2574)
Policy (59)
Postmarket research (520)
Preclinical (4291)
Press Release (66)
Prostate cancer (96)
Psychedelics (8)
Radiopharmaceuticals (177)
Rare diseases (300)
Real estate (3402)
Recruiting (22)
Regulatory (10436)
Reports (20)
Research institute (1308)
Resumes & cover letters (70)
Rett syndrome (21)
RNA editing (9)
RSV (40)
Schizophrenia (33)
Series A (164)
Series B (109)
Service/supplier (6)
Sickle cell disease (32)
Special edition (2)
Spinal muscular atrophy (60)
Sponsored (20)
Startups (2529)
State (2)
Stomach cancer (2)
Supply chain (48)
Tariffs (10)
The Weekly (23)
Vaccines (496)
Venture capital (43)
Weight loss (50)
Women's health (46)
Worklife (2)
Date
Today (25)
Last 7 days (282)
Last 30 days (1008)
Last 365 days (14712)
2026 (1425)
2025 (15079)
2024 (18769)
2023 (22167)
2022 (30905)
2021 (32565)
2020 (30596)
2019 (25867)
2018 (19511)
2017 (18902)
2016 (17803)
2015 (20610)
2014 (15209)
2013 (12759)
2012 (13810)
2011 (14148)
2010 (12873)
Location
Africa (328)
Alabama (69)
Alaska (6)
Arizona (178)
Arkansas (10)
Asia (24929)
Australia (4322)
California (5300)
Canada (1684)
China (549)
Colorado (284)
Connecticut (235)
Delaware (107)
Europe (51073)
Florida (910)
Georgia (219)
Hawaii (2)
Idaho (33)
Illinois (473)
India (33)
Indiana (263)
Iowa (8)
Japan (273)
Kansas (101)
Kentucky (15)
Louisiana (18)
Maine (22)
Maryland (722)
Massachusetts (3550)
Michigan (274)
Minnesota (408)
Mississippi (4)
Missouri (98)
Montana (27)
Nebraska (15)
Nevada (51)
New Hampshire (83)
New Jersey (1567)
New Mexico (18)
New York (1424)
North Carolina (760)
North Dakota (9)
Northern California (2245)
Ohio (169)
Oklahoma (16)
Oregon (24)
Pennsylvania (1025)
Puerto Rico (19)
Rhode Island (34)
South America (517)
South Carolina (60)
South Dakota (1)
Southern California (2272)
Tennessee (103)
Texas (877)
United States (19773)
Utah (193)
Vermont (1)
Virginia (90)
Washington D.C. (18)
Washington State (502)
West Virginia (3)
Wisconsin (87)
Wyoming (1)
377,303 Results for "awak technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Intrinsic Therapeutics Announces the First Implantation of the Barricaid® Annular Closure Device Under Awake Sedation
September 3, 2025
·
2 min read
AWAK TECHNOLOGIES RAISES US$20+ MILLION, READYING ITS WEARABLE DIALYSIS DEVICE FOR US-BASED PIVOTAL TRIAL
AWAK Technologies (AWAK), a pioneering medical technology company focused on dialysis using regeneration technology for end-stage renal disease, today announced it has successfully raised US$20+ million in Series B funding.
September 13, 2023
·
5 min read
FDA
AWAK Technologies Announces FDA Breakthrough Device Designation for their Artificial Intelligence Enabled Kidney Disease Prediction Tool
AWAK Technologies today announced that its kidney disease progression prediction (KDPP) Artificial Intelligence (AI) model for CKD patient care has been granted Breakthrough Device designation by the U.S. Food and Drug Administration (FDA).
November 27, 2023
·
4 min read
Business
AWAK Technologies and Singapore General Hospital launch pre-pivotal clinical trial of wearable peritoneal dialysis device
AWAK Technologies (AWAK) and Singapore General Hospital (SGH) announce the launch of a pre-pivotal clinical trial with the enrolment of their first subject to study the safety and efficacy of an improved Automated Wearable Artificial Kidney Peritoneal Dialysis (AWAK PD) device.
June 19, 2023
·
5 min read
Lone Star Bio
Wenzel Spine Announces First Awake Spinal Fusion Using VariLift®-LX
Wenzel Spine, a leader in the development of innovative stand-alone spinal fusion technologies and diagnostic methods, announced today a notable achievement in the company’s history with the first awake spinal fusion procedure using the VariLift®-LX interbody implant.
July 21, 2022
·
3 min read
Regulatory
6 Biotechs With a Shot at the FDA’s Platform Technology Designation
After revoking Sarepta’s award in July and awarding one to Krystal last month, the FDA’s platform technology designation program appears to be back on track. These six biotechs could be on the regulator’s radar.
November 21, 2025
·
9 min read
·
Tristan Manalac
Press Releases
Zelluna promotes Emilie Gauthy to Chief Technology Officer
February 3, 2026
·
2 min read
Press Releases
Avant Technologies Highlights the Critical Role of Cell Encapsulation Technology in Revolutionizing Diabetes Treatment
December 17, 2025
·
5 min read
Press Releases
Artis BioSolutions Announces Agreement to Acquire Syngoi Technologies to Deliver Next Generation Solutions for Synthetic DNA Technology
January 6, 2026
·
4 min read
Pharm Country
Loki Therapeutics Announces Publication in Science Translational Medicine Demonstrating Potential of AWAKE-LM-TT as a Treatment for Pancreatic Cancer
Loki Therapeutics today announced the publications of research in the journal, “Science Translational Medicine”, demonstrating the potential of AWAKE-LM-TT in the treatment of pancreatic cancer
March 28, 2022
·
4 min read
1 of 37,731
Next
